Genetic Landscape of Male Breast Cancer
Open Access
- 15 July 2021
- Vol. 13 (14), 3535
- https://doi.org/10.3390/cancers13143535
Abstract
Male breast cancer (MBC) is now considered molecularly different from female breast cancer (FBC). Evidence from studies indicates that common genetic and epigenetic features of FBC are not shared with those diagnosed in men. Genetic predisposition is likely to play a significant role in the tumorigenesis of this rare disease. Inherited germline variants in BRCA1 and BRCA2 account for around 2% and 10% of MBC cases, respectively, and the lifetime risk of breast cancer for men harboring BRCA1 and BRCA2 mutations is 1.2% and 6.8%. As for FBC, pathogenic mutations in other breast cancer genes have also been recently associated with an increased risk of MBC, such as PALB2 and CHEK2 mutations. However, while multigene germline panels have been extensively performed for BC female patients, the rarity of MBC has resulted in limited data to allow the understanding of the magnitude of risk and the contribution of recently identified moderate penetrance genes of FBC for MBC predisposition. This review gathers available data about the germline genetic landscape of men affected by breast cancer, estimated risk associated with these genetic variants, and current guidelines for clinical management.This publication has 183 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Playing the End Game: DNA Double-Strand Break Repair Pathway ChoiceMolecular Cell, 2012
- Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplificationBreast Cancer Research and Treatment, 2012
- Mutations in BRCA2 and PALB2 in male breast cancer cases from the United StatesBreast Cancer Research and Treatment, 2010
- Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancerBreast Cancer Research and Treatment, 2010
- Male breast cancerCritical Reviews in Oncology/Hematology, 2010
- Prospective Evaluation of Risk Factors for Male Breast CancerJNCI Journal of the National Cancer Institute, 2008
- Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation CarriersJNCI Journal of the National Cancer Institute, 2007
- Is Male Breast Cancer Similar or Different than Female Breast Cancer?Breast Cancer Research and Treatment, 2004
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002